Related Experiment Video
Updated: Jun 24, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Somatic LKB1 mutations promote cervical cancer progression
Shana N Wingo1, Teresa D Gallardo, Esra A Akbay
1Division of Gynecologic Oncology, UT Southwestern Medical Center, Dallas, TX, USA.
Human Papilloma Virus (HPV) causes cervical cancer, but LKB1 tumor suppressor gene mutations drive progression to invasive disease. LKB1 inactivation predicts poor survival and can guide clinical treatment.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Human Papilloma Virus (HPV) is the primary cause of cervical cancer.
- Most HPV infections regress, but some progress to invasive cancer due to unknown host factors.
- No recurrent genetic alterations were previously identified in cervical cancers, leaving the biological basis of progression unresolved.
Purpose of the Study:
- To investigate the genetic alterations driving cervical cancer progression.
- To identify key tumor suppressor genes involved in cervical carcinogenesis.
- To explore the clinical utility of genetic markers for predicting cervical cancer outcomes.
Main Methods:
- Somatic mutation analysis of the LKB1 tumor suppressor gene in cervical cancer tissues.
- Exon sequencing and multiplex ligation probe amplification (MLPA) to detect LKB1 mutations (substitutions, microdeletions, large deletions).
- Correlation of LKB1 inactivation with disease progression and patient survival rates.
Main Results:
- Somatic mutations in the LKB1 tumor suppressor gene were found in at least 20% of cervical cancers.
- Both single nucleotide substitutions/microdeletions and large monoallelic/biallelic deletions of LKB1 were observed.
- LKB1 inactivation was significantly associated with accelerated disease progression and reduced median survival (13 months vs. >100 months).
Conclusions:
- LKB1 is a major tumor suppressor in cervical cancer, and its inactivation drives progression from HPV-induced dysplasia to invasive cancer.
- Acquired genetic alterations, specifically in LKB1, are critical for cervical cancer development.
- LKB1 status serves as a potential clinical biomarker for predicting disease recurrence and guiding therapeutic strategies.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
